Importantly, our study shows that inhibition of PCSK9 activity using several novel methods of PCSK9 inhibition, such as mAb or siRNA techniques, could be safe therapeutic strategies to treat viral infection in the future. Here, PCSK9 is linked to viral infectious disease.